title: delta-Aminolevulinate dehydratase inhibition by ascorbic acid is mediated by an oxidation system existing in the hepatic supernatant.
abstract: The effect of ascorbic acid (AA) on hepatic delta-aminolevulinic acid dehydratase (ALA-D) activity was studied. AA decreased enzyme activity by reducing maximum velocity and tended to increase the Michaelis constant. ALA-D inactivation by AA occurred similarly both in air and argonium atmosphere incubation. DTT reduced considerably the inhibitory effect of AA on ALA-D, but glutathione was ineffective in reversing inactivation. These data indicate that inhibition occurs mainly due to an acceleration of the oxidation rate mediated by the hepatic supernatant utilizing AA in sulfhydryl groups of cysteine residues present at the ALA-D active site. AA probably acts on cysteine from the ALA-D B site since cucumber and radish leaves ALA-D was not inhibited by AA (up to 16 mM). The addition of free radical scavengers to the medium did not alter ALA-D inactivation caused by AA, indicating that active oxygen species formed during AA oxidation were not directly related to -SH oxidation. The chelation of zinc ions from the enzyme by EDTA turned ALA-D more susceptible to the inhibitory effect of AA. This effect seems to involve mainly ZnB, which is known to bind to four cysteines. The present data suggest that AA may participate in the regulation of the heme biosynthesis pathway by promoting a reversible inactivation of ALA-D.
authors.affiliation: Departamento de Química, Universidade Federal de Santa Maria, Brasil.
authors.forename: F A
authors.initials: FA
authors.lastname: Beber
authors.forename: J
authors.initials: J
authors.lastname: Wollmeister
authors.forename: M J
authors.initials: MJ
authors.lastname: Brigo
authors.forename: M C
authors.initials: MC
authors.lastname: Silva
authors.forename: C N
authors.initials: CN
authors.lastname: Pereira
authors.forename: J B
authors.initials: JB
authors.lastname: Rocha
mesh_terms: D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology*; D001665:Binding Sites; D003545:Cysteine / Q000737:chemistry; D004229:Dithiothreitol / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D016166:Free Radical Scavengers / Q000494:pharmacology; D005978:Glutathione / Q000494:pharmacology; D006639:Histidine / Q000737:chemistry; D008099:Liver / Q000201:enzymology*; D008353:Mannitol / Q000494:pharmacology; D009243:NAD / Q000494:pharmacology; D010084:Oxidation-Reduction; D000623:Porphobilinogen Synthase / Q000037:antagonists & inhibitors* / Q000737:chemistry; D051381:Rats; D013438:Sulfhydryl Compounds / Q000737:chemistry; D013482:Superoxide Dismutase / Q000494:pharmacology
chemical_list: D004791:Enzyme Inhibitors; D016166:Free Radical Scavengers; D013438:Sulfhydryl Compounds; D009243:NAD; D008353:Mannitol; D006639:Histidine; D004492:Edetic Acid; D013482:Superoxide Dismutase; D000623:Porphobilinogen Synthase; D005978:Glutathione; D003545:Cysteine; D001205:Ascorbic Acid; D004229:Dithiothreitol